Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
FWD Group Holdings Limited (1828.HK)
Taikoo Shing, HK
FWD Group Holdings Limited, together with its subsidiaries, provides life insurance products and services. The company operates through Hong Kong & Macau, Thailand & Cambodia, Japan, Emerging Markets, and Corporate and Others segments. It also offers accident and health insurance, and savings plans to customers, as well as distributes related investment and other financial service products. In addition, the company underwrites general insurance, as well as provides investment related products and services. The company was formerly known as PCGI Intermediate Holdings Limited and changed its name to FWD Group Holdings Limited in August 2021. The company was incorporated in 2013 and is based in Taikoo Shing, Hong Kong.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.36% | +3.54% | -1.10% | -9.07% | -19.42% | -20.26% | -20.68% | -20.68% | -20.68% | -20.68% | -20.68% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-06 | Change |
|---|---|---|
| Strong Buy | 3 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Insurance - Life: +10.6%+20.8% ★ Q4'25: -5.4% (vs Q4'24)
-
EPS growth Insurance - Life: +13.4%+390.2% ★ Q4'25: +314.7% (vs Q4'24)
-
FCF margin FCF growth · Insurance - Life: +31.7%-44.8% Q4'25: +7.3% (vs Q4'24)
-
EBIT margin Insurance - Life: +12.4%+12.4% Q4'25: +0.0% (vs Q4'24)
-
ROIC Insurance - Life: +1.0%— Q4'25: +0.0% (vs Q4'24)
-
Share dilution Insurance - Life: +0.4%-37.4% ★ Q4'25: +35.8% (vs Q4'24)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Life: -1.05×5.32× ★
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 3 EPS Ana. |
Dec 2027 3 Rev. Ana. 3 EPS Ana. |
Dec 2028 2 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|
| Revenue |
4.81B
est: 37.85B (-87.3%)
|
36.71B
23.53B – 61.07B
-3.0% YoY
|
41.68B
27.94B – 67.55B
+13.5% YoY
|
51.30B
33.69B – 84.18B
+23.1% YoY
|
| EBITDA |
593.88M
est: -132.18M (+549.3%)
|
-128.20M
-213.26M – -82.19M
+3.0% YoY
|
-145.56M
-235.90M – -97.56M
-13.5% YoY
|
-179.17M
-293.98M – -117.64M
-23.1% YoY
|
| EBIT |
593.88M
est: -447.18M (+232.8%)
|
-433.69M
-721.49M – -278.04M
+3.0% YoY
|
-492.44M
-798.07M – -330.06M
-13.5% YoY
|
-606.14M
-994.54M – -397.98M
-23.1% YoY
|
| Net Income |
166.00M
est: 609.40M (-72.8%)
|
1.24B
907.05M – 1.57B
+103.1% YoY
|
1.61B
1.27B – 1.95B
+30.2% YoY
|
2.07B
1.86B – 2.27B
+28.4% YoY
|
| SGA |
3.78B
est: 11.82B (-68.0%)
|
11.46B
7.35B – 19.07B
-3.0% YoY
|
13.01B
8.72B – 21.09B
+13.5% YoY
|
16.02B
10.52B – 26.28B
+23.1% YoY
|
| EPS |
0.13
est: 0.64 (-79.8%)
|
1.66
1.14 – 1.97
+158.7% YoY
|
2.18
1.60 – 2.45
+31.0% YoY
|
2.60
2.34 – 2.86
+19.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-12 | B+ | 3/5 | 1/5 | 5/5 | 4/5 | 2/5 | 4/5 | 3/5 |
| 2026-06-11 | B+ | 3/5 | 1/5 | 5/5 | 4/5 | 2/5 | 4/5 | 3/5 |
| 2026-06-10 | B+ | 3/5 | 1/5 | 5/5 | 4/5 | 2/5 | 4/5 | 3/5 |
| 2026-06-09 | B+ | 3/5 | 1/5 | 5/5 | 4/5 | 2/5 | 4/5 | 3/5 |
| 2026-06-08 | B+ | 3/5 | 1/5 | 5/5 | 4/5 | 2/5 | 4/5 | 3/5 |
| 2026-06-05 | B+ | 3/5 | 1/5 | 5/5 | 4/5 | 2/5 | 4/5 | 3/5 |
| 2026-06-04 | B+ | 3/5 | 1/5 | 5/5 | 4/5 | 2/5 | 4/5 | 3/5 |
| 2026-06-03 | B+ | 3/5 | 1/5 | 5/5 | 4/5 | 2/5 | 4/5 | 3/5 |
| 2026-06-02 | B+ | 3/5 | 1/5 | 5/5 | 4/5 | 2/5 | 4/5 | 3/5 |
| 2026-06-01 | B+ | 3/5 | 1/5 | 5/5 | 4/5 | 2/5 | 4/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF ISFE.L | 0.05% | 39.6K | 0.74% |
| 2 | iShares Currency Hedged MSCI EAFE Small-Cap ETF HSCZ | 0.02% | 43.6K | 0.83% |
| 3 | iShares MSCI EAFE Small-Cap ETF SCZ | 0.02% | 2.63M | 0.40% |
| 4 | Vanguard MSCI International Small Cos Index ETF VISM.AX | 0.01% | 56.5K | 0.32% |
| 5 | iShares Core MSCI Pacific ETF IPAC | 0.01% | 199.5K | 0.09% |
| 6 | iShares MSCI World Small-Cap ETF WSML | 0.01% | 45.9K | 0.30% |
| 7 | iShares MSCI World Small Cap UCITS ETF WSML.L | 0.01% | 430.0K | 0.35% |
| 8 | iShares Core MSCI EAFE IMI Index ETF (CAD-Hedged) XFH.TO | 0.00% | 105.7K | 0.23% |
| 9 | iShares Core MSCI EAFE IMI Index ETF XEF.TO | 0.00% | 748.7K | 0.23% |
| 10 | Goldman Sachs MSCI World Private Equity Return Tracker ETF GTPE | 0.00% | 1.2K | 0.50% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Phong Thanh Huynh | Group CEO & Executive Director | 42M | male |
| Chi Kin Lau | MD of Greater China & CEO of Hong Kong | — | male |
| David John Korunic | Chief Executive Officer of Thailand & Cambodia | — | male |
| Hun Chi Chow | Group Chief Human Resources Officer | — | female |
| Jong Hoon Kim | Group Chief Digital Officer | — | male |
| Lee Yen | Group Chief Distribution & Proposition Officer | — | female |
| Sarah Salvilla | Group Chief Health Officer | — | — |
| Siddhartha Sankaran | Group CFO & Group COO | — | male |
| Binayak Dutta | Senior MD of Southeast Asia & Group Chief Business Operations Officer | — | male |
| Tzar Kai Li | Executive Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 1828.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
